Data Protection Solutions for Life Sciences.
Worldwide.

This month, we cover how regulatory shifts, AI advancements, and major initiatives like Bridge2AI-Voice, India’s Genome Project, and the EU Cybersecurity Action Plan are driving transformation across healthcare, data protection, and precision medicine.

April brought major updates in data transfer, AI regulation, and healthtech innovation—including EU adequacy extensions, new AI tools, and iliomad’s Advisory Board launch.

Regulators in Europe and the UK advance AI governance, data protection, and cybersecurity, while healthtech innovations like Owkin and Apple reshape digital healthcare.

In this edition, we cover major regulatory shifts and AI advancements shaping healthcare and data security. The U.S. tightens HIPAA security rules, the EU rolls out the European Health Data Space (EHDS) for cross-border health data exchange, and new U.S. regulations restrict sensitive health data transfers to certain countries. Meanwhile, AI is revolutionizing healthcare, with Truveta’s 10M-volunteer Genome Project, Owkin’s AI-powered drug development, and AI-driven medical scribes making waves—though accuracy concerns remain. On the data privacy front, GDPR fines have soared to €5.88B, with Ireland leading at €3.5B, and the UK ICO reports 36K data complaints and £1.27M in fines, highlighting ongoing challenges in digital security.

Our latest newsletter highlights critical updates in data privacy and healthtech from 2024, including GDPR data sharing guidelines, AI advancements like Cleerly’s imaging solutions, and ongoing challenges in data security and environmental sustainability. As we look toward 2025, we’re excited to continue driving innovation and helping navigate the evolving landscape of regulations, AI, and healthcare data management.

🌎 This month, key updates include Brazil’s introduction of a new SCC-based framework for international data transfers. 📋 The EDPB shared its evaluation of the EU-US Data Privacy Framework. 🤖 Advancements in AI-driven health solutions, such as Sanofi’s Muse for clinical trial recruitment, were also highlighted. 🧬 Discussions focused on genomics privacy, neural data protection, and the transformative role of AI in healthcare and compliance landscapes.

In October, key developments in data privacy, AI, and cybersecurity emerged, including new GDPR accountability guidance for controllers, the introduction of the UK’s Data Bill 2024, and the FDA's call for coordinated AI regulation in healthcare. High-profile data breaches also highlighted vulnerabilities in health data, underscoring the need for stronger, globally aligned privacy standards.

Get up to speed with the latest in data protection regulations and healthtech innovations, including updates from Brazil, the UK, and California, along with advancements in AI-driven healthcare solutions. Plus, explore major privacy enforcement actions and key developments shaping the future of digital health.

August was a busy month for data protection in the life sciences—here's your summer recap!